HighField Biopharmaceuticals
PrivateLast Round
VC Round
Aug 8, 2024
Total Funding Raised
$15.7M
Company Overview
HighField Biopharmaceuticals is a clinical-stage biotechnology company that develops novel lipid-based therapeutics, including immunoliposomes and lipid nanoparticles, for the treatment of cancer, diabetes, and other complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HighField Biopharmaceuticals Comparables
Compare HighField Biopharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acuitas Therapeutics | 75% | |
| NanoVation Therapeutics | 75% | |
| Genevant Sciences | 70% | |
HighField Biopharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 8, 2024 | ||||
| Series B | Dec 22, 2021 | ||||
| Series A | Sep 10, 2019 | ||||
| Angel | Dec 15, 2017 |
HighField Biopharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 杭州金投产业基金管理有限公司 | Series B |
| Hiway Capital | Series B, Series A |
| Hangzhou Finance and Investment Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2019
Raised Series A with Hiway Capital and Hangzhou Tigermed.
HighField Biopharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HighField Biopharmaceuticals's valuation, stock price, and market status.